Learn More
Medchemexpress LLC Cirtuvivint (SM08502) | 2143917-62-6 | 98.1% | 427.50 | 50 MG

Supplier: Medchemexpress LLC HY13743550MG
Cirtuvivint (SM08502) is a potent and orally active CDC-like kinase (CLK) inhibitor used for solid tumors research.
- Inhibits serine and arginine rich splicing factor (SRSF) phosphorylation
- Disrupts spliceosome activity
- Linked to inhibition of Wnt pathway-related gene and protein expression
- Induces splicing variants of Wnt pathway genes
- Significantly inhibits growth of gastrointestinal tumors in xenograft mouse models
- Decreases SRSF phosphorylation and Wnt pathway gene expression in xenograft mouse models
- Exhibits an IC50 of 0.18 μM for HT-22 cells
- Shows an EC50 of 17 nM for NCI-N87 cells
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.